This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 3834
Title
Epigenetic modification process leads to Impaired, Spermatogenesis
Upstream event
Downstream event
Key Event Relationship Overview
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding | Point of Contact | Author Status | OECD Status |
|---|---|---|---|---|---|---|
| Suppression, Estrogen receptor (ER) activity leads to Impaired, Spermatogenesis via epigenetic modifications | adjacent | Moderate | John Frisch (send email) | Under development: Not open for comment. Do not cite |
Taxonomic Applicability
Sex Applicability
| Sex | Evidence |
|---|---|
| Male | High |
Life Stage Applicability
| Term | Evidence |
|---|---|
| Adult, reproductively mature | Moderate |
Key Event Relationship Description
Epigenetic modifications are alterations that affect gene expression without altering the underlying gene sequence. Among some of the more common processes that lead to epigenetic modifications are DNA methylation and alteration of histone proteins. DNA methylation involves addition of methyl groups to DNA which causes increased or decreased gene expression. Histone proteins are small proteins that assist gene expression, DNA repair, and DNA replication; histones can be modified by the addition of methyl, acetyl, or phosphate groups, which accelerates or slows DNA expression, repair, and replication.
Spermatogenesis is the process in which germ cells develop into mature sperm in testes in male animals and hermaphrodites. Impaired spermatogenesis can result in lower mature sperm counts, problems in proper sperm function such as sperm motility, or other sperm abnormalities. Epigenetic modifications alter the levels of gene expression for loci expressing proteins involved in sperm development, impairing spermatogenesis.
Evidence Collection Strategy
This Key Event Relationship was part of an Environmental Protection Agency effort to develop AOPs that establish scientifically supported causal linkages between alternative endpoints measured using new approach methodologies (NAMs) and guideline apical endpoints measured in Tier 1 and Tier 2 test guidelines (U.S. EPA, 2025) employed by the Endocrine Disruptor Screening Program (EDSP). A series of key events that represent significant, measurable, milestones connecting molecular initiation to apical endpoints indicative of adversity were identified based on scientific review articles and empirical studies. Additionally, scientific evidence supporting the causal relationships between each pair of key events was assembled and evaluated. The present effort focused primarily on empirical studies with mammals.
Empirical studies are focused on epigenetic modifications and resulting impaired spermatogenesis, in support of development of AOP 651.
Authors of KER 3834 did a further evaluation of published peer-reviewed literature to provide additional evidence in support of the key event relationship. The literature used to support this KER began with the test guidelines and followed to primary, secondary, and/or tertiary works concerning the relevant underlying biology. In addition, search engines were used to target journal articles with ‘epigenetic modifications’, ‘sperm motility’, and ‘sperm abnormalities’ in order to locate representative empirical studies that support the key event relationship.
Following initial human effort AOP development, artificial Intelligence (AI)-assisted literature search and synthesis, using EPA-AI GPT5, was used to identify additional literature, and draft Uncertainties and Inconsistencies content of this KER page. Additionally, EPA-AI GPT5 was also used to check for additional text improvement in other sections. All content generated through this process were reviewed and verified by the KER author against literature sources, prior to inclusion.
Evidence Supporting this KER
Biological Plausibility
Epigenetic modification of DNA located in germ cells alters the levels of gene expression for loci expressing proteins involved in sperm development, with resulting impaired spermatogenesis causing lower sperm counts, problems in sperm function, and other sperm abnormalities (for review of normal epigenetic modifications in spermatogenesis, see Gunes and Kulac (2013), for review of how disruption of epigenetic modifications disrupts spermatogenesis, see Cui et al. (2025)).
Empirical Evidence
|
Species |
Duration |
Dose |
Epigenetic modfications? |
Impaired spermatogenesis? |
Summary |
Citation |
|
Mice (Mus musculus) |
5 weeks |
20-40 ug/kg body weight zearalenone (ZEA). |
yes |
yes |
Epigenetic modifications indicated by statistically significant decrease in methylation markers 5mC and 5hmC at all doses and statistically significant increase in the histone methylation marker H3K27 at all doses leading to impaired spermatogenesis indicated by statistically significant decrease in sperm motility at high dose and statistically significant increase in abnormal acrosome integrity and spermatozoa abnormality at all doses. |
Gao et al. (2019) |
|
Mice (Mus musculus) |
5 weeks |
1–10 mg/kg body weight carbendazim (CBZ). |
yes |
yes |
Epigenetic modifications indicated by statistically significant decrease in methylation markers 5mC at all doses and 5hmC at high dose and statistically significant increase in the histone methylation marker H3K27 at all doses leading to impaired spermatogenesis indicated by statistically significant decrease in sperm motility at all doses and statistically significant decrease in spermatozoa count at high dose. |
Liu et al. (2019) |
|
Mice (Mus musculus) |
56 days after birth |
20-40 ug/kg body weight zearalenone (ZEA). |
yes |
yes |
Epigenetic modifications in offspring indicated by statistically significant decrease in methylation marker 5hmC at high dose and statistically significant increase in the histone methylation marker H3K27 at high dose leading to impaired spermatogenesis indicated by statistically significant decrease in sperm motility at all doses, statistically significant decrease in spermatozoa count at high dose, and statistically significant increase in abnormal acrosome integrity at high dose. |
Men et al. (2019) |
|
Mice (Mus musculus) |
6 weeks |
50 mg/kg/body weight/day Bisphenol A (BPA) |
yes |
yes |
Epigenic modifications indicated by statistically significant change in histone mRNA, protein and methylation leading to impaired spermatogenesis indicated by statistically significant decrease in sperm motility, concentration, and hyperactivity. |
Ryu et al. (2022) |
Uncertainties and Inconsistencies
- Complications due to heterogeneity in tissue type.
- Tissue contains a variety of cell types, particularly reproductive tissue with various ages in germ cells. Care should be taken not to attribute a global pattern in epigenetic modification when there are heterogeneous cell-types present, which can be mitigated by single cell type studies in humans and laboratory rodents (Cui et al. 2025).
- Complications due to multiple epigenetic effects.
- Interactions among DNA methylation, histone modifications, and other epigenetic modifications can make it difficult to attribute impaired spermatogenesis to a particular epigenetic effect in humans and laboratory rodents (Cui et al. 2025).
Known modulating factors
Quantitative Understanding of the Linkage
Response-response Relationship
Time-scale
Known Feedforward/Feedback loops influencing this KER
Domain of Applicability
Life Stage: Adult, reproductively mature for process producing fully functional sperm.
Sex: Applies to males as related to sperm.
Taxonomic: Largely studied in lab mammals; plausible for all sexually reproductive animals that have sperm.
References
Cui Y, Deng J, Zhang Y, Du L, Jiang F, Li C, Chen W, Zhang H, He Z. 2025. Epigenetic regulation by DNA methylation, histone modifications and chromatin remodeling complexes in controlling spermatogenesis and their dysfunction with male infertility. Cellular and Molecular Life Sciences 82(1): 343.
Gao Y, Zhao Y, Zhang H, Zhang P, Liu J, Feng Y, Men Y, Li L, Shen W, Sun Z, Min L. 2019. Pubertal exposure to low doses of zearalenone disrupting spermatogenesis through ERα related genetic and epigenetic pathways. Toxicology Letters. 315: 31-38.
Gunes S, Kulac T. 2013. The role of epigenetics in spermatogenesis. Turkish Journal of Urology 39(3): 181-187.
Liu J, Zhang P, Zhao Y, Zhang H. 2019. Low dose carbendazim disrupts mouse spermatogenesis might be through estrogen receptor related histone and DNA methylation. Ecotoxicology and Environmental Safety 176: 242-249.
Men Y, Zhao Y, Zhang P, Zhang H, Gao Y, Liu J, Feng Y, Li L, Shen W, Sun Z, Min L. 2019. Gestational exposure to low-dose zearalenone disrupting offspring spermatogenesis might be through epigenetic modifications. Basic and Clinical Pharmacology and Toxicology 125(4): 382-393.
Ryu DY, Pang WK, Adegoke EO, Rahman MS, Park YJ, Pang MG. 2022. Abnormal histone replacement following BPA exposure affects spermatogenesis and fertility sequentially. Environment International 170: 107617.
U.S. Environmental Protection Agency. 2025. EDSP Test Guidelines and Guidance Document. https://www.epa.gov/test-guidelines-pesticides-and-toxic-substances/edsp-test-guidelines-and-guidance-document (retrieved 25 July 2025).
Italics indicate edits from John Frisch July 2026. A full list of updates can be found in the Change Log on the View History page.